Trial Profile
Phase II study of oral S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Mar 2009 New trial record.